Anti-SRD5A2 monoclonal antibody

Pre-made anti-SRD5A2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SRD5A2/SRD5A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0020-Ab-1/ GM-Tg-hg-IP0020-Ab-2Anti-Human SRD5A2 monoclonal antibodyHuman
GM-Tg-rg-IP0020-Ab-1/ GM-Tg-rg-IP0020-Ab-2Anti-Rat SRD5A2 monoclonal antibodyRat
GM-Tg-mg-IP0020-Ab-1/ GM-Tg-mg-IP0020-Ab-2Anti-Mouse SRD5A2 monoclonal antibodyMouse
GM-Tg-cynog-IP0020-Ab-1/ GM-Tg-cynog-IP0020-Ab-2Anti-Cynomolgus/ Rhesus macaque SRD5A2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0020-Ab-1/ GM-Tg-felg-IP0020-Ab-2Anti-Feline SRD5A2 monoclonal antibodyFeline
GM-Tg-cang-IP0020-Ab-1/ GM-Tg-cang-IP0020-Ab-2Anti-Canine SRD5A2 monoclonal antibodyCanine
GM-Tg-bovg-IP0020-Ab-1/ GM-Tg-bovg-IP0020-Ab-2Anti-Bovine SRD5A2 monoclonal antibodyBovine
GM-Tg-equg-IP0020-Ab-1/ GM-Tg-equg-IP0020-Ab-2Anti-Equine SRD5A2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0020-Ab-1/ GM-Tg-hg-IP0020-Ab-2; GM-Tg-rg-IP0020-Ab-1/ GM-Tg-rg-IP0020-Ab-2;
GM-Tg-mg-IP0020-Ab-1/ GM-Tg-mg-IP0020-Ab-2; GM-Tg-cynog-IP0020-Ab-1/ GM-Tg-cynog-IP0020-Ab-2;
GM-Tg-felg-IP0020-Ab-1/ GM-Tg-felg-IP0020-Ab-2; GM-Tg-cang-IP0020-Ab-1/ GM-Tg-cang-IP0020-Ab-2;
GM-Tg-bovg-IP0020-Ab-1/ GM-Tg-bovg-IP0020-Ab-2; GM-Tg-equg-IP0020-Ab-1/ GM-Tg-equg-IP0020-Ab-2
Products NameAnti-SRD5A2 monoclonal antibody
Formatmab
Target NameSRD5A2
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SRD5A2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0020-Ag-1Recombinant multi-species S5A2/ SRD5A2 protein
    ORF Viral VectorpGMLP004602human SRD5A2 Lentivirus plasmid
    ORF Viral VectorvGMLP004602human SRD5A2 Lentivirus particle
    ORF Viral VectorpGMLPm004612mouse Srd5a2 Lentivirus plasmid
    ORF Viral VectorvGMLPm004612mouse Srd5a2 Lentivirus particle


    Target information

    Target IDGM-IP0020
    Target NameSRD5A2
    Gene ID6716,94224,64677,705676,403715,101086898,527024,100070655
    Gene Symbol and Synonyms5ART2,S5AR 2,SRD5A2
    Uniprot AccessionP31213,P31214
    Uniprot Entry NameS5A2_HUMAN,S5A2_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseProstate disease
    Gene EnsemblENSG00000277893
    Target ClassificationN/A

    The target: SRD5A2, gene name: SRD5A2, also named as . This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH). [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.